Activin A activation drives renal fibrosis through the STAT3 signaling pathway

Int J Biochem Cell Biol. 2021 May:134:105950. doi: 10.1016/j.biocel.2021.105950. Epub 2021 Feb 17.

Abstract

The present study investigated whether TGF-β1 promotes fibrotic changes in HK-2 cells through the Activin A and STAT3 signaling pathways in vitro. Bioinformatics analysis of microarray profiles (GSE20247 and GSE23338) and a protein-protein interaction (PPI) analysis were performed to select hub genes. For the in vitro study, HK-2 cells were exposed to TGF-β1. The expression of Activin A and STAT3 was assayed, and the effect of Activin A and STAT3 expression on fibrosis was assessed (Collagen I and Fibronectin). The bioinformatics study revealed TGF-β1 and Activin A as hub genes. The in vitro study showed that Activin A expression was significantly increased after TGF-β1 incubation. Blocking Activin A attenuated TGF-β1-induced fibrosis. In addition, Activin A blockade attenuated TGF-β1-induced STAT3 signaling pathway activation and related fibrosis. More importantly, STAT3 inhibition by S3I-201 alleviated TGF-β1-induced fibrosis. Activin A promoted cellular fibrotic changes through the STAT3 signaling pathway. Attenuating Activin A expression to mediate the STAT3 signaling pathway might be a strategy for potent renal fibrosis treatment.

Keywords: Activin A; Bioinformatics analysis; Renal fibrosis; STAT3; TGF-β.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activins / metabolism*
  • Cell Line
  • Databases, Genetic
  • Epithelial-Mesenchymal Transition
  • Fibrosis / metabolism
  • Fibrosis / pathology
  • Humans
  • Kidney Diseases / metabolism*
  • Kidney Diseases / pathology*
  • STAT3 Transcription Factor / metabolism*
  • Signal Transduction
  • Transforming Growth Factor beta1 / metabolism*

Substances

  • STAT3 Transcription Factor
  • STAT3 protein, human
  • TGFB1 protein, human
  • Transforming Growth Factor beta1
  • activin A
  • Activins